Covid-19: India gas maker shares jump amid shortage of life-saving oxygen

Supplies of medical oxygen, essential in many cases to treat seriously ill patients, have been depleted as hospitals around India have been overwhelmed by Covid-19 cases

Oxygen
A Covid-19 patient waits to be allocated a bed at LNJP Hospital, amid shortage of beds and medical oxygen, as coronavirus cases surge in record numbers across the country, in New Delhi (Photo: PTI)
Nupur Acharya | Bloomberg
1 min read Last Updated : Apr 23 2021 | 11:45 PM IST
An acute shortage of medical oxygen in India, amid a deadly wave of coronavirus infections, has triggered a surge in stocks seen linked to industrial gases.

Supplies of medical oxygen, essential in many cases to treat seriously ill patients, have been depleted as hospitals around India have been overwhelmed by Covid-19 cases. The nation recorded 314,835 new infections on Thursday, the world’s biggest one-day jump, and taking its case-count to almost 16 million, the second-most globally.

Workers load refilled oxygen tanks into a vehicle at a refill station in Navi Mumbai, India, on Thursday, April 22, 2021. India saw a record one-day jump with more than 300,000 new coronavirus infections, marking a grim milestone for the country as a deadlier second wave showing no signs of abating.

 
Oxygen manufacturer Linde India Ltd. has gained more than 90% so far this year, while National Oxygen Ltd. has advanced 59%.

Even a company that doesn’t make or supply industrial gases, much less high-in-demand oxygen, has surged: While there’s no evidence that investors are buying Bombay Oxygen Investments Ltd. because of its name, shares in the firm with a market cap of $44 million have gained 132% from a Jan. 29 low.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineOxygen

Next Story